Motilal Oswal NASDAQ 100 ETF
Motilal Oswal NASDAQ 100 ETF Fundamental Analysis
Motilal Oswal NASDAQ 100 ETF (MON100.NS) shows weak financial fundamentals with a PE ratio of 33.11, profit margin of 0.00%, and ROE of 0.00%. The company generates N/A in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 25.0/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze MON100.NS's fundamental strength across five key dimensions:
Efficiency Score
WeakMON100.NS struggles to generate sufficient returns from assets.
Valuation Score
WeakMON100.NS trades at a premium to fair value.
Growth Score
ModerateMON100.NS shows steady but slowing expansion.
Financial Health Score
ModerateMON100.NS shows balanced financial health with some risks.
Profitability Score
WeakMON100.NS struggles to sustain strong margins.
Key Financial Metrics
Is MON100.NS Expensive or Cheap?
P/E Ratio
MON100.NS trades at 33.11 times earnings. This suggests a premium valuation.
Debt/Equity
Motilal Oswal NASDAQ 100 ETF has a debt-to-equity ratio of 0.00, indicating its leverage.
How Well Does MON100.NS Make Money?
Net Profit Margin
For every $100 in sales, Motilal Oswal NASDAQ 100 ETF keeps $0.00 as profit after all expenses.
Operating Margin
Core operations generate 0.00 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $0.00 in profit for every $100 of shareholder equity.
ROA
Motilal Oswal NASDAQ 100 ETF generates $0.00 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
FCF Per Share
Each share generates $0.00 in free cash annually.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
N/A
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
N/A
vs 25 benchmark
P/B Ratio
Price to book value ratio
N/A
vs 25 benchmark
P/S Ratio
Price to sales ratio
N/A
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.00
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.00
vs 25 benchmark
ROA
Return on assets percentage
0.00
vs 25 benchmark
ROCE
Return on capital employed
0.00
vs 25 benchmark
How MON100.NS Stacks Against Its Sector Peers
| Metric | MON100.NS Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | N/A | 18.79 | N/A |
| ROE | 0.00% | 848.00% | Weak |
| Net Margin | 0.00% | 2879.00% | Weak |
| Debt/Equity | 0.00 | 0.93 | Strong (Low Leverage) |
| Current Ratio | 0.00 | 675.55 | Weak Liquidity |
| ROA | 0.00% | -20989.00% (disorted) | Weak |
MON100.NS outperforms its industry in 1 out of 5 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Motilal Oswal NASDAQ 100 ETF's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Value, Dividend, Cyclical
EPS CAGR
N/A
Industry Style: Value, Dividend, Cyclical
FCF CAGR
N/A
Industry Style: Value, Dividend, Cyclical